Herzuma is given by a doctor or nurse and billed by the clinic, not a pharmacy. Your care team and your insurance decide which product you get, so ask them what you’d pay.

How do you pay?

How to pay the least

Given by your care team

Billed by the clinic

Herzuma is given by a doctor or nurse, not picked up at a pharmacy.

  1. Ask your care team or your plan what you’d pay before your visit.

Compare every option

Question
Brand nameHerzuma
Authorized generictrastuzumab
Regular generictrastuzumab
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldAsk the pharmacy
Same as Herzuma?
The original
–
–

Brand nameThe maker’s card

HERZUMA Cost Support Program (Copay Card)

Savings card from Teva (Cephalon)

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a prescription

Sign up on herzuma.com 

Or call 1-888-587-3263.

In the maker’s words

“Enroll in the HERZUMA Cost Support Program to receive cost support and pay as little as $0.”

From the maker’s offer on herzuma.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Authorized genericNot sold

There isn’t one. An authorized generic is Herzuma itself, from the same company, sold without the brand name, and usually for less. For now Herzuma is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

Herzuma is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

HERZUMA is a HER2/neu receptor antagonist indicated in adults for:

  • the treatment of HER2-overexpressing breast cancer.
  • the treatment of HER2-overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma.

Select patients for therapy based on an FDA-approved companion diagnostic for a trastuzumab product.

Source: the FDA label for Herzuma (Cephalon, Inc.), December 22, 2025. Full label on DailyMed 

Good to know